Toward a serum biomarker of disease activity in Susac syndrome
European Journal of Neurology · 2023
DOI: 10.1111/ene.15984 ↗Kurz gefasst
Kommentar in der Zeitschrift European Journal of Neurology, 2023. Verfasst von Todd A Hardy. Beteiligte Einrichtung: Multiple Sclerosis and Neuroimmunology Clinic, Concord Repatriation General Hospital, University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Susac Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Multiple Sclerosis and Neuroimmunology Clinic, Concord Repatriation General Hospital, University of Sydney, Sydney, New South Wales, Australia.
- Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Todd A Hardy
Zitieren
APA
Hardy, T. A. (2023). Toward a serum biomarker of disease activity in Susac syndrome. European Journal of Neurology. https://doi.org/10.1111/ene.15984
Vancouver
Hardy TA. Toward a serum biomarker of disease activity in Susac syndrome. European Journal of Neurology. 2023. doi:10.1111/ene.15984
BibTeX
@article{Hardy2023,
author = {Hardy, Todd A},
title = {Toward a serum biomarker of disease activity in Susac syndrome},
journal = {European Journal of Neurology},
year = {2023},
doi = {10.1111/ene.15984}
}
EUVIMED